𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized trial of 2 dosages of prophylactic granulocyte–colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia

✍ Scribed by Hiroto Inaba; Xueyuan Cao; Stanley Pounds; Ching-Hon Pui; Jeffrey E. Rubnitz; Raul C. Ribeiro; Bassem I. Razzouk

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
155 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of de novo acute myelogenous l
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: Effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts
✍ Valent, Peter ;Sillaber, Christian ;Geissler, Klaus ;Andreeff, Michael ;Tafuri, 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

GM-CSF is a major regulator of myelopoiesis. Recombinant human GM-CSF (250 micrograms/m2 per day i.v.) was used prior to chemotherapy ("3 + 7" scheme) to recruit leukemic blasts in vivo (de novo AML patients, n = 20) into the chemotherapy sensitive phases of the cell cycle. The stimulatory effect of